ID   CHLA-247
AC   CVCL_AQ14
DR   Wikidata; Q54812191
RX   PubMed=24792489;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,15
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 14,14.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ15 ! CHLA-253
OI   CVCL_AX48 ! CHLA-253h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
RX   PubMed=24792489; DOI=10.1007/s11060-014-1456-8;
RA   Farooqi A.S., Dagg R.A., Choi L.M.R., Shay J.W., Reynolds C.P.,
RA   Lau L.M.S.;
RT   "Alternative lengthening of telomeres in neuroblastoma cell lines is
RT   associated with a lack of MYCN genomic amplification and with p53
RT   pathway aberrations.";
RL   J. Neurooncol. 119:17-26(2014).
//